Trial Profile
A Single-blind Crossover Study of the Pharmacokinetic and Postprandial Glucose Dynamics of BIOD-531 Compared to Humulin R U-500 and Humalog Mix 75/25 in Subjects With Type 2 Diabetes Mellitus Who Are Treated With 50-200 Units of Insulin Per Day
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin neutral protamine lispro/insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Biodel
- 08 Oct 2014 New trial record
- 11 Aug 2014 Positive preliminary results published in Biodel media release.
- 11 Aug 2014 Status changed from active, no longer recruiting to completed, according to a Biodel media release.